Silverfin false false 28/02/2025 28/02/2025 01/03/2024 no description of principal activity Yolanda Sydney Augustin 09/02/2021 Professor Sanjeev Krishna 09/02/2021 13189786 2025-02-28 13189786 bus:Director1 2025-02-28 13189786 bus:Director2 2025-02-28 13189786 2024-02-29 13189786 core:CurrentFinancialInstruments 2025-02-28 13189786 core:CurrentFinancialInstruments 2024-02-29 13189786 2024-03-01 2025-02-28 13189786 bus:Micro-entities 2024-03-01 2025-02-28 13189786 bus:FilletedAccounts 2024-03-01 2025-02-28 13189786 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 13189786 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13189786 bus:Director1 2024-03-01 2025-02-28 13189786 bus:Director2 2024-03-01 2025-02-28 13189786 2023-03-01 2024-02-29 iso4217:GBP xbrli:pure

Company No: 13189786 (England and Wales)

# CENTRE FOR AFFORDABLE DIAGNOSTICS AND THERAPEUTICS LIMITED

### Unaudited Financial Statements
For the financial year ended 28 February 2025
Pages for filing with the registrar

CENTRE FOR AFFORDABLE DIAGNOSTICS AND THERAPEUTICS LIMITED

## UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 28 February 2025

Contents

CENTRE FOR AFFORDABLE DIAGNOSTICS AND THERAPEUTICS LIMITED

## BALANCE SHEET

As at 28 February 2025
CENTRE FOR AFFORDABLE DIAGNOSTICS AND THERAPEUTICS LIMITED

## BALANCE SHEET (continued)

For the financial year ended 28 February 2025

|  | 2025 |  | 2024
|  | £ |  | £
Current assets |  | 11,611 |  | 8,970
Creditors: amounts falling due within one year |  | ( 85,535) |  | ( 38,441)
Net current liabilities |  | ( 73,924) |  | ( 29,471)
Total assets less current liabilities |  | ( 73,924) |  | ( 29,471)
Net liabilities |  | ( 73,924) |  | ( 29,471)
Capital and reserves |  | ( 73,924) |  | ( 29,471)

For the financial year ending 28 February 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Centre For Affordable Diagnostics And Therapeutics Limited (registered number: 13189786) were approved and authorised for issue by the Board of Directors on 20 February 2026 and were signed on its behalf by:

Professor Sanjeev Krishna Director |

CENTRE FOR AFFORDABLE DIAGNOSTICS AND THERAPEUTICS LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 28 February 2025
CENTRE FOR AFFORDABLE DIAGNOSTICS AND THERAPEUTICS LIMITED

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 28 February 2025

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 13189786). The address of its registered office is 2 Leman Street, London, E1W 9US, United Kingdom.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the financial year, including directors | 2 |  | 2